2023 FDA TIDES (Peptides and Oligonucleotides) Harvest.

Authors:
Al Shaer D; Al Musaimi O; Albericio F; de la Torre BG.

Journal:
Pharmaceuticals (Basel)

Publication Year: 2024

DOI:
10.3390/ph17020243

PMCID:
PMC10893093

PMID:
38399458

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharmaceuticals (Basel)

Abbreviation: Pharmaceuticals (Basel)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
1,2,4-Triazole-Tethered Indolinones as New Cancer-Fighting Small Molecules Targeting VEGFR-2: Synth…
Elsawi AE; Shahin MI; Elbendary HA and 3 more (2024) - Transparency Score: 3/6
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice.
Zhang C; Su H; Waight E and 4 more (2024) - Transparency Score: 3/6
A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Cr…
Kokoszka A. (2024) - Transparency Score: 3/6
A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular…
Chen LZ; Roos D; Philip E and 4 more (2024) - Transparency Score: 3/6
A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease…
Kalsoom S; Rasool MF; Imran I and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest Author Danah Al Shaer was employed by the company Evotec. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The authors express their gratitude to Newcastle University."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025